Dr. Ravi Diwan, MD

Dr. Diwan practices at Cardiovascular Associates of the Delaware Valley,P A in Neptune, New Jersey.

Dr. Diwan's NPI, 1376792382, was assigned on September 15, 2008. Dr. Diwan graduated from Royal College of Surgeons Ireland in 2006. Dr. Diwan holds New Jersey license 25MA09273100.

Dr. Diwan's primary practice is Cardiovascular Associates of the Delaware Valley,P A, at 1 Hwy 35, Neptune, NJ 07753 in Monmouth County. The practice phone is (856) 547-0539.

Dr. Diwan's primary practice is Cardiovascular Associates of the Delaware Valley,P A in Neptune, New Jersey. Dr. Diwan is also affiliated with Jersey Shore University Medical Center. The medical group on file is Hackensack Meridian Medical Group. Dmand AI also links Dr. Diwan to 3 more hospitals, 5 medical groups and 4 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Diwan practices, 8 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Diwan's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Diwan's licenses on file in 2 states: New Jersey and New York.

CMS data shows 7,830 Medicare services from Dr. Diwan across 33 procedure codes in 2024, for 1,362 Medicare patients. Medicare paid $1,145,117 for them.

CMS counts 1,362 Medicare patients who saw Dr. Diwan in 2024. The largest group is 65 to 74, with 547 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Diwan's median patient age at 71, with 48% women.

In 2024, Dr. Diwan wrote 7,303 Medicare Part D claims for 1,103 patients. 82% of them were for generic drugs. CMS names the drug for 6,952 of them, across 68 drugs with 11 or more claims each, at $1,997,646 in total drug cost. In 2023, CMS named 6,149 claims across 68 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Diwan for performance year 2024, reported as part of a group. Dr. Diwan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 55 procedures of coronary angioplasty and stenting by Dr. Diwan, more than 86% of the clinicians it reports for that procedure.

Dmand AI links 5 papers to Dr. Diwan. The most frequent topics are Coronary Angiography, Angiography and Angioplasty, Balloon, Coronary. Dr. Diwan has published most often in J Invasive Cardiol. Dr. Diwan's most frequent co-authors are Tak W. Kwan, MD, Justin Anthony Ratcliffe, MD and Tejas Patel, MD.

CMS Open Payments shows 1,543 general payments to Dr. Diwan from 58 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Abbott Laboratories paid the most, $7,696.

Dr. Diwan graduated from Royal College of Surgeons Ireland in 2006.